Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Dermatology Drug market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Dermatology Drug market. Detailed analysis of key players, along with key growth strategies adopted by Dermatology Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Bayer
AbbVie
Merz Pharma
Novartis
GlaxoSmithKline
Bristol-Myers Squibb
Galderma
Johnson & Johnson
LEO Pharma
Valeant
Pfizer
By Type:
External Use
Oral
Injection
By End-User:
Psoriasis
Skin Infections
Acne
Dermatitis
Other
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Dermatology Drug Market
-
1.3 Market Segment by Type
-
1.3.1 China Dermatology Drug Market Size and Growth Rate of External Use from 2016 to 2027
-
1.3.2 China Dermatology Drug Market Size and Growth Rate of Oral from 2016 to 2027
-
1.3.3 China Dermatology Drug Market Size and Growth Rate of Injection from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Dermatology Drug Market Size and Growth Rate of Psoriasis from 2016 to 2027
-
1.4.2 China Dermatology Drug Market Size and Growth Rate of Skin Infections from 2016 to 2027
-
1.4.3 China Dermatology Drug Market Size and Growth Rate of Acne from 2016 to 2027
-
1.4.4 China Dermatology Drug Market Size and Growth Rate of Dermatitis from 2016 to 2027
-
1.4.5 China Dermatology Drug Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Dermatology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Dermatology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Dermatology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Dermatology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Dermatology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Dermatology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Dermatology Drug Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Dermatology Drug Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Dermatology Drug by Major Types
-
3.4.1 Market Size and Growth Rate of External Use
-
3.4.2 Market Size and Growth Rate of Oral
-
3.4.3 Market Size and Growth Rate of Injection
4 Segmentation of Dermatology Drug Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Dermatology Drug by Major End-Users
-
4.4.1 Market Size and Growth Rate of Dermatology Drug in Psoriasis
-
4.4.2 Market Size and Growth Rate of Dermatology Drug in Skin Infections
-
4.4.3 Market Size and Growth Rate of Dermatology Drug in Acne
-
4.4.4 Market Size and Growth Rate of Dermatology Drug in Dermatitis
-
4.4.5 Market Size and Growth Rate of Dermatology Drug in Other
5 Market Analysis by Regions
-
5.1 China Dermatology Drug Production Analysis by Regions
-
5.2 China Dermatology Drug Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Dermatology Drug Landscape Analysis
-
6.1 North China Dermatology Drug Landscape Analysis by Major Types
-
6.2 North China Dermatology Drug Landscape Analysis by Major End-Users
7 Central China Dermatology Drug Landscape Analysis
-
7.1 Central China Dermatology Drug Landscape Analysis by Major Types
-
7.2 Central China Dermatology Drug Landscape Analysis by Major End-Users
8 South China Dermatology Drug Landscape Analysis
-
8.1 South China Dermatology Drug Landscape Analysis by Major Types
-
8.2 South China Dermatology Drug Landscape Analysis by Major End-Users
9 East China Dermatology Drug Landscape Analysis
-
9.1 East China Dermatology Drug Landscape Analysis by Major Types
-
9.2 East China Dermatology Drug Landscape Analysis by Major End-Users
10 Northeast China Dermatology Drug Landscape Analysis
-
10.1 Northeast China Dermatology Drug Landscape Analysis by Major Types
-
10.2 Northeast China Dermatology Drug Landscape Analysis by Major End-Users
11 Southwest China Dermatology Drug Landscape Analysis
-
11.1 Southwest China Dermatology Drug Landscape Analysis by Major Types
-
11.2 Southwest China Dermatology Drug Landscape Analysis by Major End-Users
12 Northwest China Dermatology Drug Landscape Analysis
-
12.1 Northwest China Dermatology Drug Landscape Analysis by Major Types
-
12.2 Northwest China Dermatology Drug Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Bayer
-
13.1.1 Bayer Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 AbbVie
-
13.2.1 AbbVie Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Merz Pharma
-
13.3.1 Merz Pharma Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Novartis
-
13.4.1 Novartis Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 GlaxoSmithKline
-
13.5.1 GlaxoSmithKline Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Bristol-Myers Squibb
-
13.6.1 Bristol-Myers Squibb Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Galderma
-
13.7.1 Galderma Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Johnson & Johnson
-
13.8.1 Johnson & Johnson Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 LEO Pharma
-
13.9.1 LEO Pharma Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Valeant
-
13.10.1 Valeant Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 Pfizer
-
13.11.1 Pfizer Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Dermatology Drug Market Size and Growth Rate of External Use from 2016 to 2027
-
Figure China Dermatology Drug Market Size and Growth Rate of Oral from 2016 to 2027
-
Figure China Dermatology Drug Market Size and Growth Rate of Injection from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Dermatology Drug Market Size and Growth Rate of Psoriasis from 2016 to 2027
-
Figure China Dermatology Drug Market Size and Growth Rate of Skin Infections from 2016 to 2027
-
Figure China Dermatology Drug Market Size and Growth Rate of Acne from 2016 to 2027
-
Figure China Dermatology Drug Market Size and Growth Rate of Dermatitis from 2016 to 2027
-
Figure China Dermatology Drug Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Dermatology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Dermatology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Dermatology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Dermatology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Dermatology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Dermatology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Dermatology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Dermatology Drug Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Dermatology Drug
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Dermatology Drug by Different Types from 2016 to 2027
-
Table Consumption Share of Dermatology Drug by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of External Use
-
Figure Market Size and Growth Rate of Oral
-
Figure Market Size and Growth Rate of Injection
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Dermatology Drug by Different End-Users from 2016 to 2027
-
Table Consumption Share of Dermatology Drug by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Psoriasis
-
Figure Market Size and Growth Rate of Skin Infections
-
Figure Market Size and Growth Rate of Acne
-
Figure Market Size and Growth Rate of Dermatitis
-
Figure Market Size and Growth Rate of Other
-
Table China Dermatology Drug Production by Regions
-
Table China Dermatology Drug Production Share by Regions
-
Figure China Dermatology Drug Production Share by Regions in 2016
-
Figure China Dermatology Drug Production Share by Regions in 2021
-
Figure China Dermatology Drug Production Share by Regions in 2027
-
Table China Dermatology Drug Consumption by Regions
-
Table China Dermatology Drug Consumption Share by Regions
-
Figure China Dermatology Drug Consumption Share by Regions in 2016
-
Figure China Dermatology Drug Consumption Share by Regions in 2021
-
Figure China Dermatology Drug Consumption Share by Regions in 2027
-
Table North China Dermatology Drug Consumption by Types from 2016 to 2027
-
Table North China Dermatology Drug Consumption Share by Types from 2016 to 2027
-
Figure North China Dermatology Drug Consumption Share by Types in 2016
-
Figure North China Dermatology Drug Consumption Share by Types in 2021
-
Figure North China Dermatology Drug Consumption Share by Types in 2027
-
Table North China Dermatology Drug Consumption by End-Users from 2016 to 2027
-
Table North China Dermatology Drug Consumption Share by End-Users from 2016 to 2027
-
Figure North China Dermatology Drug Consumption Share by End-Users in 2016
-
Figure North China Dermatology Drug Consumption Share by End-Users in 2021
-
Figure North China Dermatology Drug Consumption Share by End-Users in 2027
-
Table Central China Dermatology Drug Consumption by Types from 2016 to 2027
-
Table Central China Dermatology Drug Consumption Share by Types from 2016 to 2027
-
Figure Central China Dermatology Drug Consumption Share by Types in 2016
-
Figure Central China Dermatology Drug Consumption Share by Types in 2021
-
Figure Central China Dermatology Drug Consumption Share by Types in 2027
-
Table Central China Dermatology Drug Consumption by End-Users from 2016 to 2027
-
Table Central China Dermatology Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Dermatology Drug Consumption Share by End-Users in 2016
-
Figure Central China Dermatology Drug Consumption Share by End-Users in 2021
-
Figure Central China Dermatology Drug Consumption Share by End-Users in 2027
-
Table South China Dermatology Drug Consumption by Types from 2016 to 2027
-
Table South China Dermatology Drug Consumption Share by Types from 2016 to 2027
-
Figure South China Dermatology Drug Consumption Share by Types in 2016
-
Figure South China Dermatology Drug Consumption Share by Types in 2021
-
Figure South China Dermatology Drug Consumption Share by Types in 2027
-
Table South China Dermatology Drug Consumption by End-Users from 2016 to 2027
-
Table South China Dermatology Drug Consumption Share by End-Users from 2016 to 2027
-
Figure South China Dermatology Drug Consumption Share by End-Users in 2016
-
Figure South China Dermatology Drug Consumption Share by End-Users in 2021
-
Figure South China Dermatology Drug Consumption Share by End-Users in 2027
-
Table East China Dermatology Drug Consumption by Types from 2016 to 2027
-
Table East China Dermatology Drug Consumption Share by Types from 2016 to 2027
-
Figure East China Dermatology Drug Consumption Share by Types in 2016
-
Figure East China Dermatology Drug Consumption Share by Types in 2021
-
Figure East China Dermatology Drug Consumption Share by Types in 2027
-
Table East China Dermatology Drug Consumption by End-Users from 2016 to 2027
-
Table East China Dermatology Drug Consumption Share by End-Users from 2016 to 2027
-
Figure East China Dermatology Drug Consumption Share by End-Users in 2016
-
Figure East China Dermatology Drug Consumption Share by End-Users in 2021
-
Figure East China Dermatology Drug Consumption Share by End-Users in 2027
-
Table Northeast China Dermatology Drug Consumption by Types from 2016 to 2027
-
Table Northeast China Dermatology Drug Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Dermatology Drug Consumption Share by Types in 2016
-
Figure Northeast China Dermatology Drug Consumption Share by Types in 2021
-
Figure Northeast China Dermatology Drug Consumption Share by Types in 2027
-
Table Northeast China Dermatology Drug Consumption by End-Users from 2016 to 2027
-
Table Northeast China Dermatology Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Dermatology Drug Consumption Share by End-Users in 2016
-
Figure Northeast China Dermatology Drug Consumption Share by End-Users in 2021
-
Figure Northeast China Dermatology Drug Consumption Share by End-Users in 2027
-
Table Southwest China Dermatology Drug Consumption by Types from 2016 to 2027
-
Table Southwest China Dermatology Drug Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Dermatology Drug Consumption Share by Types in 2016
-
Figure Southwest China Dermatology Drug Consumption Share by Types in 2021
-
Figure Southwest China Dermatology Drug Consumption Share by Types in 2027
-
Table Southwest China Dermatology Drug Consumption by End-Users from 2016 to 2027
-
Table Southwest China Dermatology Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Dermatology Drug Consumption Share by End-Users in 2016
-
Figure Southwest China Dermatology Drug Consumption Share by End-Users in 2021
-
Figure Southwest China Dermatology Drug Consumption Share by End-Users in 2027
-
Table Northwest China Dermatology Drug Consumption by Types from 2016 to 2027
-
Table Northwest China Dermatology Drug Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Dermatology Drug Consumption Share by Types in 2016
-
Figure Northwest China Dermatology Drug Consumption Share by Types in 2021
-
Figure Northwest China Dermatology Drug Consumption Share by Types in 2027
-
Table Northwest China Dermatology Drug Consumption by End-Users from 2016 to 2027
-
Table Northwest China Dermatology Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Dermatology Drug Consumption Share by End-Users in 2016
-
Figure Northwest China Dermatology Drug Consumption Share by End-Users in 2021
-
Figure Northwest China Dermatology Drug Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
Table Company Profile and Development Status of AbbVie
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
-
Figure Sales and Growth Rate Analysis of AbbVie
-
Figure Revenue and Market Share Analysis of AbbVie
-
Table Product and Service Introduction of AbbVie
-
Table Company Profile and Development Status of Merz Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merz Pharma
-
Figure Sales and Growth Rate Analysis of Merz Pharma
-
Figure Revenue and Market Share Analysis of Merz Pharma
-
Table Product and Service Introduction of Merz Pharma
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of Bristol-Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
-
Table Product and Service Introduction of Bristol-Myers Squibb
-
Table Company Profile and Development Status of Galderma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Galderma
-
Figure Sales and Growth Rate Analysis of Galderma
-
Figure Revenue and Market Share Analysis of Galderma
-
Table Product and Service Introduction of Galderma
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
Table Company Profile and Development Status of LEO Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of LEO Pharma
-
Figure Sales and Growth Rate Analysis of LEO Pharma
-
Figure Revenue and Market Share Analysis of LEO Pharma
-
Table Product and Service Introduction of LEO Pharma
-
Table Company Profile and Development Status of Valeant
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant
-
Figure Sales and Growth Rate Analysis of Valeant
-
Figure Revenue and Market Share Analysis of Valeant
-
Table Product and Service Introduction of Valeant
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
